{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:17:59Z","timestamp":1787001479660,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:thro.0000024053.45693.fc","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T21:13:42Z","timestamp":1082063622000},"page":"155-161","source":"Crossref","is-referenced-by-count":36,"title":["Atrial Fibrillation and Hypercoagulability: Dependent on Clinical Factors or\/and on Genetic Alterations?"],"prefix":"10.1007","volume":"16","author":[{"given":"Eleni","family":"Hatzinikolaou-Kotsakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarifis","family":"Kartasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tziakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Hotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Stakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsatalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Bourikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Kotsakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios I.","family":"Hatseras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5268635_CR1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Emerson T Jr, Kannel WB. Epidemiologic assessment of Chronic atrial fibrillation and risk of Stroke: The Framingham Study. Neurology 1978;28:973-977.","journal-title":"Neurology"},{"key":"5268635_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.STR.21.1.47","volume":"21","author":"C Gustafsson","year":"1990","unstructured":"Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in non-valvular atrial fibrillation. Stroke 1990;21:47-51.","journal-title":"Stroke"},{"key":"5268635_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archneur.1986.00520010065026","volume":"43","author":"Cerebral Embolism Task Force.","year":"1986","unstructured":"Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71-84.","journal-title":"Arch Neurol"},{"key":"5268635_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0735-1097(90)90589-H","volume":"16","author":"K Kumagai","year":"1990","unstructured":"Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hori N. Increased inta-cardiovascular clotting in patients with chronic atrial fibrillation. J AmColl Cardiol 1990;16:377-380.","journal-title":"J AmColl Cardiol"},{"key":"5268635_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00001721-199806000-00001","volume":"9","author":"AD Blann","year":"1998","unstructured":"Blann AD, Lip GYH. The endothelium in cardiovascular disease: Functions, assessment and implications. Blood Coag and Fibrinol 1998;9:297-306.","journal-title":"Blood Coag and Fibrinol"},{"key":"5268635_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0021-9150(96)05980-1","volume":"128","author":"AD Blann","year":"1997","unstructured":"Blann AD, Lip GYH. Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997;128:135-138.","journal-title":"Atherosclerosis"},{"key":"5268635_CR7","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/S0002-9149(97)89115-1","volume":"77","author":"SM Sopher","year":"1996","unstructured":"Sopher SM, Camm AJ. Atrial Fibrillation: Maintenance of sinus rhythm versus rate control. Am J Cardiol 1996;77:24A-37A.","journal-title":"Am J Cardiol"},{"key":"5268635_CR8","first-page":"301","volume":"29","author":"GYH Lip","year":"1999","unstructured":"Lip GYH. How would I manage a 60 year old man presenting with atrial fibrillation? Proceedings of the Royal College of Physians of Edinburgh 1999;29:301-306.","journal-title":"Proceedings of the Royal College of Physians of Edinburgh"},{"key":"5268635_CR9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0140-6736(93)90998-V","volume":"341","author":"PM Ridker","year":"1993","unstructured":"Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168.","journal-title":"Lancet"},{"key":"5268635_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0038-1653820","volume":"73","author":"K Kontula","year":"1995","unstructured":"Kontula K, Ylikorkala A, Miettinen H, et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558-560.","journal-title":"Thromb Haemost"},{"key":"5268635_CR11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","volume":"342","author":"T Koster","year":"1993","unstructured":"Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-1506.","journal-title":"Lancet"},{"key":"5268635_CR12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","volume":"346","author":"DC Rees","year":"1995","unstructured":"Rees DC, Cox M, Clewgg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134.","journal-title":"Lancet"},{"key":"5268635_CR13","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3_-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.","journal-title":"Blood"},{"key":"5268635_CR14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","volume":"79","author":"FR Rosendaal","year":"1998","unstructured":"Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210A G to A prothrombin variant. Thromb Haemost 1998;79:706-708.","journal-title":"Thromb Haemost"},{"key":"5268635_CR15","first-page":"155","volume":"88","author":"GYH Lip","year":"1995","unstructured":"Lip GYH. Fibrinogen and cardiovascular disease. QJM 1995;88:155-165.","journal-title":"QJM"},{"key":"5268635_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.73.6.527","volume":"73","author":"GYH Lip","year":"1995","unstructured":"Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: Efects of warfarin therapy. Br Heart J 1995;73: 527-533.","journal-title":"Br Heart J"},{"key":"5268635_CR17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1365-2141.1998.00883.x","volume":"102","author":"T Pernerstorfer","year":"1998","unstructured":"Pernerstorfer T, Stohlawatz P, Stummvoll G, et al. Low dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haem 1998;102:1229-1231.","journal-title":"Br J Haem"},{"key":"5268635_CR18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0002-8703(96)90278-1","volume":"131","author":"GYH Lip","year":"1996","unstructured":"Lip GYH, Lowe GDO, Rumley A, Dunn F. Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence of intermidiate levels of intravascular thrombogenesis. Am Heart J 1996;131:724-730.","journal-title":"Am Heart J"},{"key":"5268635_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(96)00427-5","volume":"29","author":"H Sohara","year":"1997","unstructured":"Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a timedependent manner: A study in patients with paroxysmal atrial fibrillation. J AmColl Cardiol 1997;29:106-112.","journal-title":"J AmColl Cardiol"},{"key":"5268635_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0167-5273(95)02434-X","volume":"51","author":"GYH Lip","year":"1995","unstructured":"Lip GYH, Rumley A, Dunn FG, Lowe GD. Plasma fibrinogen and fibrin D-dimer levels in atrial fibrillation: Effect of cardioversion to sinus rhythm. Int J Cardiol 1995;51: 245-253.","journal-title":"Int J Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:THRO.0000024053.45693.fc.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:THRO.0000024053.45693.fc\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:THRO.0000024053.45693.fc.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:26:40Z","timestamp":1754638000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:THRO.0000024053.45693.fc"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["5268635"],"URL":"https:\/\/doi.org\/10.1023\/b:thro.0000024053.45693.fc","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}